Enhancing adherence in randomized controlled clinical trials

被引:59
作者
Shumaker, SA
Dugan, E
Bowen, DJ
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源
CONTROLLED CLINICAL TRIALS | 2000年 / 21卷 / 05期
关键词
patient compliance; patient noncompliance; retention; treatment refusal; patient dropouts; attitude to health;
D O I
10.1016/S0197-2456(00)00083-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This paper identifies individual and systematic primary, secondary, and tertiary prevention approaches that can be used to enhance adherence in randomized controlled trials. Specifically, strategies such as these are discussed: careful screening during enrollment, use of a run-in period, fully informing participants of the study burden, explaining randomization, determining the participant's prior history with treatment interventions, establishing and using a tracking system, clearly specifying adherence measures, and staff training in communication and negotiation. These strategies have been gathered over time from our experiences working in multiple randomized controlled trials. Research on factors that promote or detract from adherence should be a standard part of randomized controlled trials. Control Clin Trials 2000;21:226S-232S (C) Elsevier Science Inc. 2000.
引用
收藏
页码:226S / 232S
页数:7
相关论文
共 3 条
[1]  
CLARK NM, 1998, HDB HLTH BEHAV CHANG
[2]  
MURDAUGH CL, 1998, HDB HLTH BEHAV CHANG
[3]  
Rand CS, 1998, HDB HLTH BEHAV CHANG